Brokerages Expect Abbott Laboratories (ABT) Will Announce Quarterly Sales of $7.37 Billion

Saturday, 13 Jan, 2018

Clifford Swan Investment Counsel Llc who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $102.61B market cap company. The stock decreased 0.92% or $0.54 during the last trading session, reaching $58.09. About 833,612 shares traded.

Equities analysts predict that Abbott Laboratories (NYSE:ABT) will post $7.37 billion in sales for the current fiscal quarter, according to Zacks Investment Research. It has underperformed by 21.19% the S&P500.

Mark Sheptoff Financial Planning Llc decreased its stake in Cardinal Health Inc (CAH) by 83.4% based on its latest 2017Q3 regulatory filing with the SEC. Finally, RBC Capital Markets reduced their price target on shares of Abbott Laboratories from $48.00 to $46.00 and set an "outperform" rating on the stock in a report on Thursday, January 26th. Moreover, Sit Investment Associates Inc has 0.3% invested in the company for 1.01 million shares. Stuyvesant Capital Management who had been investing in Mcewen Mng Inc for a number of months, seems to be bullish on the $802.01M market cap company. The stock decreased 1.12% or $0.96 during the last trading session, reaching $84.74. About 1.09 million shares traded or 159.89% up from the average. It has outperformed by 7.70% the S&P500. Vanguard Group Inc. raised its stake in shares of Abbott Laboratories by 2.6% during the second quarter. The business's revenue for the quarter was up 2.8% on a year-over-year basis. (NYSE:GIS), 2 have Buy rating, 4 Sell and 17 Hold. 24,693 shares were sold by Comstock Elizabeth J, worth $633,375. Also, insider Alejandro D. Wellisch sold 2,153 shares of the business's stock in a transaction that occurred on Wednesday, November 22nd. ValuEngine cut Abbott Laboratories from a "buy" rating to a "hold" rating in a research note on Friday, December 1st. Therefore 31% are positive. General Electric Company had 81 analyst reports since July 21, 2015 according to SRatingsIntel. Canaccord Genuity maintained it with "Buy" rating and $525 target in Thursday, May 11 report. The stock has "Buy" rating by S&P Research on Tuesday, October 20. The company was downgraded on Thursday, October 29 by Barclays Capital. Stifel Nicolaus upgraded Equinix, Inc. As per Thursday, July 23, the company rating was maintained by Stifel Nicolaus. Robert W. Baird maintained American Water Works Company, Inc. (NASDAQ:REIT) rating on Wednesday, December 6. Canaccord Genuity maintained the shares of EQIX in report on Monday, May 23 with "Buy" rating. (NYSE:MPW) has "Buy" rating given on Monday, August 14 by Jefferies. Also, insider Daniel Gesua Sive Salvadori sold 71,157 shares of the firm's stock in a transaction dated Tuesday, November 14th. RBC Capital Markets maintained Ralph Lauren Corporation (NYSE:RL) rating on Tuesday, April 11.

Investors sentiment decreased to 0.87 in Q3 2017. ABT's profit will be $1.27B for 20.15 P/E if the $0.73 EPS becomes a reality. It improved, as 40 investors sold Ralph Lauren Corporation shares while 111 reduced holdings. 59 funds opened positions while 177 raised stakes. Ngam Advsrs Ltd Partnership invested in 0.24% or 424,824 shares. Insiders own 0.76% of the company's stock. Zurcher Kantonalbank (Zurich Cantonalbank) holds 171,524 shares or 0.11% of its portfolio. 6,129 are held by M&T Bank Corp. Bollard Ltd Limited Liability Company holds 118,544 shares. (NASDAQ:REIT) for 155 shares. Koch Indus accumulated 0.17% or 13,547 shares. Perigon Wealth Management Ltd Liability Corp holds 0.07% or 474 shares. Assetmark stated it has 1,654 shares or 0% of all its holdings. Camarda Financial Advsr has 55 shares. Fukoku Mutual Life Ins invested in 37,200 shares or 0.13% of the stock. Massachusetts Financial Co Ma, a Massachusetts-based fund reported 49.17 million shares. Investors of record on Friday, January 12th will be issued a dividend of $0.28 per share. Its down 0.95, from 2.18 in 2017Q2. The ratio turned negative, as 532 investment professionals opened new and increased holdings, while 610 trimmed and sold positions in Abbott Laboratories. River Road Asset Mgmt Llc owns 541,950 shares or 0.71% of their United States portfolio. 275.05 million shares or 0.51% more from 273.65 million shares in 2017Q2 were reported. Jefferies reinitiated Abbott Laboratories (NYSE:ABT) on Thursday, June 29 with "Buy" rating. 424,859 were accumulated by Commerce Commercial Bank. This is a positive change from Abbott Laboratories's previous quarterly dividend of $0.27.

TRADEMARK VIOLATION WARNING: "62,415 Shares in Abbott Laboratories (ABT) Purchased by Stratos Wealth Partners LTD." was originally posted by The Lincolnian Online and is owned by of The Lincolnian Online. The company has a total of 1.47 Billion shares outstanding. Banque Pictet & Cie Sa holds 403,734 shares. 291.21 million shares or 2.54% less from 298.80 million shares in 2017Q2 were reported. The insider now holds 63,556 shares of Abbott Laboratories (ABT).

Abbott Laboratories (ABT) surprised the stock market in its last reported earnings when it earned $0.66 a piece versus the consensus-estimated $0.65. Pekin Singer Strauss Asset Management Il reported 0.21% stake. Burney, a Virginia-based fund reported 150,255 shares. BMO Capital Markets restated a "market perform" rating on shares of Abbott Laboratories in a research note on Thursday, October 19th. After $0.66 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 10.61% EPS growth. 2,000 Abbott Laboratories (NYSE:ABT) shares with value of $98,323 were sold by Bracken Sharon J.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on January, 24 before the open. $9.73 million worth of stock was sold by Fussell Stephen R on Wednesday, August 16.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.